Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
3,127
+1,182
+61% +$405K 0.38% 50
2026
Q1
$684K Buy
1,945
+188
+11% +$67K 0.31% 49
2025
Q4
$606K Buy
1,757
+1,318
+300% +$418K 0.2% 57
2025
Q3
$124K Buy
439
+187
+74% +$54.2K 0.08% 76
2025
Q2
$70.4K Hold
252
0.07% 73
2025
Q1
$79K Buy
252
+209
+486% +$61.7K 0.07% 70
2024
Q4
$11K Buy
43
+34
+378% +$10.1K 0.01% 102
2024
Q3
$3K Hold
9
﹤0.01% 91
2024
Q2
$3K Buy
+9
New +$2.64K ﹤0.01% 69

Other funds holding AMGN

E Fund Management (HK)'s AMGN Position: Q2 2026 in Review

E Fund Management (HK) increased its Amgen (AMGN) stake by 61% in Q2 2026, buying an estimated $405K and bringing the position to 3,127 shares worth $1.13M. The position accounts for 0.38% of the portfolio, ranked #50.

E Fund Management (HK) first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • E Fund Management (HK) held 3,127 shares of Amgen worth $1.13M as of Q2 2026.
  • E Fund Management (HK) bought 1,182 Amgen shares in Q2 2026, an estimated $405K.
  • Amgen made up 0.38% of E Fund Management (HK)'s portfolio in Q2 2026, its #50 holding.
  • E Fund Management (HK) first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.